Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Ryerson Holding Q2 EPS $5.31 Beats $4.58 Estimate

Ryerson Holding (NYSE:RYI) reported quarterly earnings of $5.31 per share which beat the analyst consensus estimate of $4.58 by 15.94 percent. This is a 328.23 percent increase over earnings of $1.24 per share from the
byBenzinga Newsdesk
August 3, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Ryerson Holding (NYSE:RYI) reported quarterly earnings of $5.31 per share which beat the analyst consensus estimate of $4.58 by 15.94 percent. This is a 328.23 percent increase over earnings of $1.24 per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

GSK Announced Jemperli RUBY Phase III Trial Met Primary Endpoint in Planned Interim Analysis in Patients With Primary Advanced or Recurrent Endometrial Cancer

By Charles Gross
December 2, 5:46 AM
GSK plc (LSE/NYSE: GSK) today announced positive headline results from the planned interim analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial investigating Jemperli (dostarlimab) plus standard-of-care chemotherapy (carboplatin-paclitaxel) followed by Jemperli compared to chemotherapy plus placebo followed by placebo in adult patients with primary advanced or recurrent endometria

GSK